Government-related group British International Investment and Lucknow-based Small Industries Development Bank of India are among the Mumbai firm's limited partners in earlier funds.
If deals had been struck at 'market' prices instead of climate premia, net IRRs could have been been boosted by up to 7%, says new CREO Advisory report.
The seed-stage investor aims to close the gap in funding for start-ups tackling water-based climate issues.
Hans Swildens weighs in on Industry's sale to Goldman Sachs, who the most active sellers in the venture secondaries market are, the current NAV discount for venture assets and lots more.
The multi-strategy asset manager raised $270m for Fund XIV, surpassing its target of $200m.
The Miami-based firm touts its leadership’s experience in healthcare recruiting as a key part of its strategy.
Megan Maloney, who just closed on $8m for her debut fund, explains her investment thesis and why she sometimes feels like Han Solo.
The investment bank will pay up to $965m for Industry, as it ramps up its push into private wealth, focusing on distributions and unique product offerings.
The multi-medicine biotechnology investor is led by a pair of MDs who share an alma mater.
The New York-based investment firm counts on more than 75 LPs to raise $1.36bn for EIP Flagship Fund III.